Understanding cancer predisposition in Singapore: what's next

Knowledge of an underlying genetic predisposition to cancer allows the use of personalised prognostic, preventive and therapeutic strategies for the patient and carries clinical implications for family members. Despite great progress, we identified six challenging areas in the management of patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Chiang, Jianbang, Shaw, Tarryn, Ngeow, Joanne
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/169417
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-169417
record_format dspace
spelling sg-ntu-dr.10356-1694172023-07-23T15:38:01Z Understanding cancer predisposition in Singapore: what's next Chiang, Jianbang Shaw, Tarryn Ngeow, Joanne Lee Kong Chian School of Medicine (LKCMedicine) National Cancer Centre Singapore Duke‑NUS Medical School Science::Medicine Cancer Genetics Genetic Testing Knowledge of an underlying genetic predisposition to cancer allows the use of personalised prognostic, preventive and therapeutic strategies for the patient and carries clinical implications for family members. Despite great progress, we identified six challenging areas in the management of patients with hereditary cancer predisposition syndromes and suggest recommendations to aid in their resolution. These include the potential for finding unexpected germline variants through somatic tumour testing, optimal risk management of patients with hereditary conditions involving moderate-penetrance genes, role of polygenic risk score in an under-represented Asian population, management of variants of uncertain significance, clinical trials in patients with germline pathogenic variants and technology in genetic counselling. Addressing these barriers will aid the next step forward in precision medicine in Singapore. All stakeholders in healthcare should be empowered with genetic knowledge to fully leverage the potential of novel genomic insights and implement them to provide better care for our patients. Published version 2023-07-18T02:47:35Z 2023-07-18T02:47:35Z 2023 Journal Article Chiang, J., Shaw, T. & Ngeow, J. (2023). Understanding cancer predisposition in Singapore: what's next. Singapore Medical Journal, 64(1), 37-44. https://dx.doi.org/10.4103/singaporemedj.SMJ-2021-468 0037-5675 https://hdl.handle.net/10356/169417 10.4103/singaporemedj.SMJ-2021-468 36722515 2-s2.0-85147187071 1 64 37 44 en Singapore Medical Journal © 2023 Singapore Medical Journal. Published by Wolters Kluwer - Medknow. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
Cancer Genetics
Genetic Testing
spellingShingle Science::Medicine
Cancer Genetics
Genetic Testing
Chiang, Jianbang
Shaw, Tarryn
Ngeow, Joanne
Understanding cancer predisposition in Singapore: what's next
description Knowledge of an underlying genetic predisposition to cancer allows the use of personalised prognostic, preventive and therapeutic strategies for the patient and carries clinical implications for family members. Despite great progress, we identified six challenging areas in the management of patients with hereditary cancer predisposition syndromes and suggest recommendations to aid in their resolution. These include the potential for finding unexpected germline variants through somatic tumour testing, optimal risk management of patients with hereditary conditions involving moderate-penetrance genes, role of polygenic risk score in an under-represented Asian population, management of variants of uncertain significance, clinical trials in patients with germline pathogenic variants and technology in genetic counselling. Addressing these barriers will aid the next step forward in precision medicine in Singapore. All stakeholders in healthcare should be empowered with genetic knowledge to fully leverage the potential of novel genomic insights and implement them to provide better care for our patients.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Chiang, Jianbang
Shaw, Tarryn
Ngeow, Joanne
format Article
author Chiang, Jianbang
Shaw, Tarryn
Ngeow, Joanne
author_sort Chiang, Jianbang
title Understanding cancer predisposition in Singapore: what's next
title_short Understanding cancer predisposition in Singapore: what's next
title_full Understanding cancer predisposition in Singapore: what's next
title_fullStr Understanding cancer predisposition in Singapore: what's next
title_full_unstemmed Understanding cancer predisposition in Singapore: what's next
title_sort understanding cancer predisposition in singapore: what's next
publishDate 2023
url https://hdl.handle.net/10356/169417
_version_ 1773551264838189056